<p>Cells were treated with different concentrations of HMGB1 for the indicated time periods. Cell viability was determined using CCK8 assay. Data from three independent experiments was shown as mean±SD; <i>n</i> = 3. CCK8, cell counting kit; HMGB1, high-mobility group box-1; SD, standard deviation.</p
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p>After MG-63 and MC3T3-E1 cells were cultured at 37°C for 12 h, 24 h, and 48 h in the bore of the ...
<p>Cells were incubated with various concentrations of HMF for 24 h, after which cell viability was ...
<p>Effect of HMGB1 on cell growth. CCK-8 assay showed that inhibition of HMGB1 expression in HCCLM6 ...
<p>Cells were treated with 1, 10, and 100 ng/mL of HMGB1 for 24 h. (A) Cytotoxicity was detected by ...
<p>RAW 264.7 cells were treated with the indicated amount of HMGB1 for 24, 48 or 72 hours. <b>A:</b>...
<p>(A) NF-κB p65 subcellular distribution in bEnd.3 cells treated with HMGB1 for indicated durations...
<p>(A&B) The mRNA levels of <i>mdr1a</i> (A) and TLR4 (B) in bEnd.3 cells treated with different con...
<p>(A) Cells were treated with LPS at various concentrations for 48 hr. Cell culture media were coll...
<p><b>A:</b> Timeline of the cell-based screening: RAW 264.7 cells were pre-treated with test compou...
<p>(A) HMGB1 was either added to the upper transwell chamber containing the cells (haptotactic stimu...
<p>(A) qRT-PCR analysis of HMGB3 expression in six CRC cell lines. The differences between independe...
<p>C<sub>2</sub>C<sub>12</sub> myoblasts were treated with either 25 μM or 125 μM free acid HMB or v...
<p>Cells pretreated with 2 μM of different inhibitors (A) or transfected with lentiviral based shRNA...
<p>(A) Stimulating HMEC-1 cells with recombinant HMGB1 in control media for 2 hours induced the secr...
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p>After MG-63 and MC3T3-E1 cells were cultured at 37°C for 12 h, 24 h, and 48 h in the bore of the ...
<p>Cells were incubated with various concentrations of HMF for 24 h, after which cell viability was ...
<p>Effect of HMGB1 on cell growth. CCK-8 assay showed that inhibition of HMGB1 expression in HCCLM6 ...
<p>Cells were treated with 1, 10, and 100 ng/mL of HMGB1 for 24 h. (A) Cytotoxicity was detected by ...
<p>RAW 264.7 cells were treated with the indicated amount of HMGB1 for 24, 48 or 72 hours. <b>A:</b>...
<p>(A) NF-κB p65 subcellular distribution in bEnd.3 cells treated with HMGB1 for indicated durations...
<p>(A&B) The mRNA levels of <i>mdr1a</i> (A) and TLR4 (B) in bEnd.3 cells treated with different con...
<p>(A) Cells were treated with LPS at various concentrations for 48 hr. Cell culture media were coll...
<p><b>A:</b> Timeline of the cell-based screening: RAW 264.7 cells were pre-treated with test compou...
<p>(A) HMGB1 was either added to the upper transwell chamber containing the cells (haptotactic stimu...
<p>(A) qRT-PCR analysis of HMGB3 expression in six CRC cell lines. The differences between independe...
<p>C<sub>2</sub>C<sub>12</sub> myoblasts were treated with either 25 μM or 125 μM free acid HMB or v...
<p>Cells pretreated with 2 μM of different inhibitors (A) or transfected with lentiviral based shRNA...
<p>(A) Stimulating HMEC-1 cells with recombinant HMGB1 in control media for 2 hours induced the secr...
<p>(A) Nuclear NF-κB p65 protein levels in bEnd.3 cells treated with HMGB1 plus different inhibitors...
<p>After MG-63 and MC3T3-E1 cells were cultured at 37°C for 12 h, 24 h, and 48 h in the bore of the ...
<p>Cells were incubated with various concentrations of HMF for 24 h, after which cell viability was ...